---
title: 3.8 Important drug interactions
---

import Expander from '../../../src/components/Expander'

  
 Concomitant administration of a benzodiazepine with a drug which is sedative (eg alcohol) or which reduces blood pressure (eg ACE inhibitor) can increase the potential for these effects.  
  
Consult summaries of product characteristics and other sources of information on the interactions of individual benzodiazepines.

  


<table>
 <tr>
  <th>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </th>
  <th>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </th>
  <th>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </th>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
  <td>
   <p>
    <strong>
     Interacting drug or drug class
    </strong>
   </p>
   <p>
    <strong>
     Effect of interaction
    </strong>
   </p>
   <p>
    <strong>
     Risk-reduction measures
    </strong>
   </p>
   <p>
    <strong>
     Drugs that reduce blood pressure:
    </strong>
   </p>
   <ul>
    <li>
     ACE inhibitors and angiotensin-II receptor antagonists
    </li>
    <li>
     Alpha1 adrenoceptor antagonists (eg alfuzosin, doxazosin, indoramin, prazosin, tamsulosin, terazosin)
    </li>
    <li>
     Beta-blockers
    </li>
    <li>
     Calcium-channel blockers
    </li>
    <li>
     Clonidine
    </li>
    <li>
     Diazoxide
    </li>
    <li>
     Diuretics (thiazide eg bendroflumethiazide and loop eg furosemide)
    </li>
    <li>
     Methyldopa
    </li>
    <li>
     Moxonidine
     <br/>
     Nitrates (glyceryl trinitrate, isosorbide dinitrate, isosorbide mononitrate)
Increased hypotensive effect
    </li>
   </ul>
   <p>
    Monitor blood pressure
   </p>
   <p>
    <strong>
     Drugs that cause sedation
    </strong>
    (either as their primary effect or as an unwanted effect):
   </p>
   <ul>
    <li>
     Alcohol
    </li>
    <li>
     Anaesthetics, general
    </li>
    <li>
     Antidepressants (including tricyclic antidepressants and mirtazapine)
    </li>
    <li>
     Antihistamines[^1], sedative
    </li>
    <li>
     Antipsychotics
    </li>
    <li>
     Lofexidine
    </li>
    <li>
     Moxonidine
    </li>
    <li>
     Opioid analgesics
    </li>
    <li>
     Tizanidine
Increased sedation and increased risk of respiratory depression and hypotension.
    </li>
   </ul>
   <p>
    Combined disinhibitory[^2] effects of alcohol and a benzodiazepine may increase the possibility of aggressive behaviour.
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^3] impairment.
   </p>
   <p>
    Effects on respiration and blood pressure may need to be monitored when initiating treatment or increasing the dose.
   </p>
   <p>
    Baclofen
   </p>
   <p>
    Increased sedation
   </p>
   <p>
    Warn individual of excessive sedation and psychomotor[^4] impairment
   </p>
   <p>
    Cimetidine
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    Disulfiram
   </p>
   <p>
    Benzodiazepine effect increased
   </p>
   <p>
    <strong>
     Enzyme-inducing drugs such as:
    </strong>
   </p>
   <ul>
    <li>
     Carbamazepine
    </li>
    <li>
     Phenobarbital
    </li>
    <li>
     Rifampicin
Enzyme induction may reduce benzodiazepine effect
    </li>
   </ul>
   <p>
    Levodopa
   </p>
   <p>
    Antiparkinsonian effect of levodopa may be reduced rarely
   </p>
   <p>
    Phenytoin
   </p>
   <p>
    Benzodiazepines may raise or lower the concentration of phenytoin in blood
   </p>
   <p>
    Ritonavir
   </p>
   <p>
    Effect of benzodiazepine increased—risk of excessive CNS depression
   </p>
   <p>
    Avoid concomitant use, especially of alprazolam, diazepam and flurazepam
   </p>
   <p>
    Sodium oxybate
   </p>
   <p>
    Effect of sodium oxybate increased
   </p>
   <p>
    Avoid concomitant use of a benzodiazepine and sodium oxybate
   </p>
  </td>
 </tr>
</table>



[^1]: A substance that blocks the effects of histamine. Histamine is released when the body mounts an immune response and it is responsible for many allergy-related symptoms


[^2]: Loss of inhibition which can lead to lack of restraint and disregard for social conventions


[^3]: Level of consciousness or cognitive ability linked to motor behaviour


[^4]: Level of consciousness or cognitive ability linked to motor behaviour
